Gilead Sciences acquires our drug for first-in-progress T cell engagement program for autoimmune diseases

Gilead Sciences acquires our drug for first-in-progress T cell engagement program for autoimmune diseases

FOSTER CITY, Calif.–( BUSINESS WIRE )–Gilead Sciences, Inc. (Nasdaq: GILD) announced today that it has entered into a definitive agreement to acquire Oro Pharmaceuticals, a privately held biotechnology company focused on developing T cell-mediated therapies for autoimmune diseases. “This acquisition underscores our commitment to developing transformative therapies for people living with serious autoimmune diseases,” said … Read more

A dietitian reveals her No. 1 red flag to avoid in a weight loss program

A dietitian reveals her No. 1 red flag to avoid in a weight loss program

Losing weight is a complex and highly individual process. The truth is that it often takes some time, especially if you are doing it yourself by making lifestyle changes. Still, there are plenty of diets that promise quick results—and plenty of persuasive influencers promoting them. When starting a weight loss program, it can be tempting … Read more